What should be done if a patient with advanced lung cancer and bone metastases experiences pain again after taking targeted therapy for six months?

In general, if a patient with advanced lung cancer and bone metastasis experiences pain again after six months of taking targeted therapy, it may be due to pathological factors such as the development of drug resistance. It could also result from lung cancer bone metastasis or pathological fractures. Patients should receive symptomatic treatment based on the specific cause. The detailed analysis is as follows:

1. Non-pathological factors

If patients with advanced lung cancer take the same medication for a prolonged period, their bodies may develop drug tolerance. When the same dose is taken again, the drug may no longer produce the expected effect. It is recommended that patients promptly consult their doctor and switch to another pain-relieving medication.

2. Pathological factors

1) Bone metastasis from lung cancer

When bone metastasis occurs in patients with advanced lung cancer, cancer cells continuously invade the bones, causing pain. As the condition worsens, existing medications may no longer effectively control the disease. It is recommended that patients seek treatment at a qualified medical institution, where radiotherapy can be used to relieve symptoms and prolong survival.

2) Pathological fracture

In patients with advanced lung cancer who have bone metastasis, severe bone destruction may lead to pathological fractures, resulting in pain. It is recommended that patients, under medical supervision, use medications such as celecoxib capsules or indomethacin tablets for treatment.

If patients with advanced lung cancer and bone metastasis experience any discomfort, they should seek timely medical attention to avoid delayed treatment and potentially serious consequences.